In our earlier study [41], we reported on the capacity of four novel CMC analogs to inhibit tyrosinase enzyme activity in an acellular system as well as melanogenesis in B16F10 mouse melanoma cells; we have further begun to elucidate the mechanisms by which they inhibit melanogenesis. This evidence concerns the gene TYR and melanoma.